Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/164109
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | RGD cadherins and α2β1 integrin in cancer metastasis: a dangerous liaison |
Autor: | Casal, J. Ignacio CSIC ORCID ; Bartolomé, Rubén Álvaro CSIC ORCID | Palabras clave: | CDH6 Cadherin 17 Metastasis RGD motif Therapeutic antibodies Type IV collagen VE-cadherin α2β1 integrin |
Fecha de publicación: | 16-abr-2018 | Editor: | Elsevier | Citación: | Biochim Biophys Acta S0304-419X(18)30055-6 (2018) | Resumen: | We propose a new cadherin family classification comprising epithelial cadherins (cadherin 17 [CDH17], cadherin 16, VE-cadherin, cadherin 6 and cadherin 20) containing RGD motifs within their sequences. Expression of some RGD cadherins is associated with aggressive forms of cancer during the late stages of metastasis, and CDH17 and VE-cadherin have emerged as critical actors in cancer metastasis. After binding to α2β1 integrin, these cadherins promote integrin β1 activation, and thereby cell adhesion, invasion and proliferation, in liver and lung metastasis. Activation of α2β1 integrin provokes an affinity increase for type IV collagen, a major component of the basement membrane and a critical partner for cell anchoring in liver and other metastatic organs. Activation of α2β1 integrin by RGD motifs breaks an old paradigm of integrin classification and supports an important role of this integrin in cancer metastasis. Recently, synthetic peptides containing the RGD motif of CDH17 elicited highly specific and selective antibodies that block the ability of CDH17 RGD to activate α2β1 integrin. These monoclonal antibodies inhibit metastatic colonization in orthotopic mouse models of liver and lung metastasis for colorectal cancer and melanoma, respectively. Hopefully, blocking the cadherin RGD ligand capacity will give us control over the integrin activity in solid tumors metastasis, paving the way for development of new agents of cancer treatment. | Descripción: | 47 p.-3 fig.-1 tab. | Versión del editor: | http://dx.doi.org/10.1016/j.bbcan.2018.04.005 | URI: | http://hdl.handle.net/10261/164109 | DOI: | 10.1016/j.bbcan.2018.04.005 | ISSN: | 0304-419X |
Aparece en las colecciones: | (CIB) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
BBA Reviews on Cancer_2018.pdf | Postprint | 7,65 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
29
checked on 27-mar-2024
WEB OF SCIENCETM
Citations
26
checked on 27-feb-2024
Page view(s)
247
checked on 29-mar-2024
Download(s)
1.050
checked on 29-mar-2024
Google ScholarTM
Check
Altmetric
Altmetric
Este item está licenciado bajo una Licencia Creative Commons